We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock

Delisted

DICE was delisted on the 8th of August, 2023.

0 hedge funds and large institutions have $0 invested in DICE Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 159 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1600 (-160)

100% less funds holding in top 10

Funds holding in top 10: 100 (-10)

100% less capital invested

Capital invested by funds: $2.11B → $0 (-$2.11B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 159

Holders
Holders Change
-160
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
159
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
-$5.99M -128,937 Closed
DCM
52
DAFNA Capital Management
California
-$5.93M -127,585 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
-$5.37M -115,496 Closed
Qube Research & Technologies (QRT)
54
Qube Research & Technologies (QRT)
United Kingdom
-$5.31M -114,335 Closed
GCIA
55
Gabelli & Co Investment Advisers
New York
-$4.98M -107,250 Closed
Janus Henderson Group
56
Janus Henderson Group
United Kingdom
-$4.81M -103,629 Closed
TS
57
Twin Securities
New York
-$4.26M -91,680 Closed
SCM
58
Soleus Capital Management
Connecticut
-$3.72M -80,000 Closed
CG
59
Carmignac Gestion
France
-$3.27M -70,439 Closed
CS
60
Credit Suisse
Switzerland
-$3.22M -69,258 Closed
FC
61
FORA Capital
Florida
-$3.06M -65,810 Closed
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
-$3M -64,449 Closed
EFI
63
EHP Funds Inc
Canada
-$2.97M -64,000 Closed
Swiss National Bank
64
Swiss National Bank
Switzerland
-$2.9M -62,400 Closed
GI
65
GAMCO Investors
Connecticut
-$2.84M -61,100 Closed
Ohio Public Employees Retirement System (OPERS)
66
Ohio Public Employees Retirement System (OPERS)
Ohio
-$2.79M -60,000 Closed
CSS
67
Cubist Systematic Strategies
Connecticut
-$2.77M -59,557 Closed
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
-$2.48M -53,286 Closed
Allianz Asset Management
69
Allianz Asset Management
Germany
-$2.44K -52,600 Closed
PCM
70
Prelude Capital Management
New York
-$2.27M -48,757 Closed
WMSA
71
Weiss Multi-Strategy Advisers
New York
-$2.26M -48,705 Closed
HHGC
72
Hunting Hill Global Capital
New York
-$1.97M -42,454 Closed
TC
73
Trium Capital
United Kingdom
-$1.83K -39,449 Closed
UBS AM
74
UBS AM
Illinois
-$1.13M -39,422 Closed
SG Americas Securities
75
SG Americas Securities
New York
-$1.8M -38,785 Closed

DICE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q3 2023, worth a combined $0 — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 159 funds closed out of DICE and 0 opened new positions — a net loss of 159 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $365M sold.

  • 0 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q3 2023, down from 160 in Q2 2023.
  • Funds reported $0 of DICE Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q3 2023 and 159 closed out, a net change of -159 holders.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q3 2023 was RA Capital Management, an estimated $365M sold.

Based on aggregated 13F filings for Q3 2023.